Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells

Oncology Reports

Volumn 17, Issue 4, 2007, Pages 903-907

  Fernandez Cobo, Mariana ^a   Zammarchi, Francesca ^b   Mandeli, John ^a   Holland, James F ^a   Pogo, Beatriz G T ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer; Wnt10B; Wnt5A

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT10B PROTEIN, HUMAN; WNT5A PROTEIN, HUMAN;

ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; GENETICS; HUMAN; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; HUMANS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; WNT PROTEINS;

EID: 34249934694     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.4.903     Document Type: Article

References (26)

1. Brennan KR and Brown AM: Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia 9: 119-131, 2004. (Pubitemid 39177498)
2. Reguart N, He B, Taron M, You L, Jablons DM and Rosell R: The role of Wnt signaling in cancer and stem cells. Fut Oncol 1: 787-797, 2005.
3. Nusse R and Varmus HE: Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99-109, 1982.
4. Smalley MJ and Dale TC: Wnt signaling and mammary tumorigenesis. J Mammary Gland Biol Neoplasia 6: 37-52, 2001. (Pubitemid 33640645)
5. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell PR and Hung MC: Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97: 4262-4266, 2000. (Pubitemid 30226121)
6. Jonsson M, Borg A, Nilbert N and Andersson T: Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer. Eur J Cancer 36: 242-248, 2000. (Pubitemid 30102202)
7. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
8. Candidus S, Bischoff P, Becker KF and Hofler H: No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. Cancer Res 56: 49-52, 1996. (Pubitemid 26011460)
9. Schlosshauer PW, Brown SA, Eisinger K, Yan Q, Guglielminetti ER, Parsons R, Ellenson LH and Kitajewski J: APC truncation and increased beta-catenin levels in a human breast cancer cell line. Carcinogenesis 21: 1453-1456, 2000. (Pubitemid 30456006)
10. Howe LR and Brown AM: Wnt signaling and breast cancer. Cancer Biol Ther 3: 36-41, 2004.
11. Pukrop T, Klemm F, Hagemann T, Gradl D, Schulz M, Siemes S, Trumper L and Binder C: Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci USA 103: 5454-5459, 2006.
12. Dejmek J, Leandersson K, Manjer J, Bjartell A, Emdin SO, Vogel WF, Landberg G and Andersson T: Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival. Clin Cancer Res 11: 520-528, 2005. (Pubitemid 40116875)
13. Bui TD, Tortora G, Ciardiello F and Harris AL: Expression of Wnt5a is down-regulated by extracellular matrix and mutated c-Ha-ras in the human mammary epithelial cell line MCF-10A. Biochem Biophys Res Commun 239: 911-917, 1997. (Pubitemid 27504202)
14. Lejeune S, Huguet EL, Hamby A, Poulsom R and Harris AL: Wnt5a cloning, expression, and up-regulation in human primary breast cancers. Clin Cancer Res 1: 215-222, 1995.
15. Iozzo RV, Eichstetter I and Danielson KG: Aberrant expression of the growth factor Wnt-5A in human malignancy. Cancer Res 55: 3495-3499, 1995.
16. Dairkee SH, Ji Y, Ben Y, Moore DH, Meng Z and Jeffrey SS: A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue. BMC Genomics 5: 47, 2004.
17. Sandberg R and Ernberg I: The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles. Genome Biol 6: R65, 2005.
18. Fernandez-Cobo M, Holland JF and Pogo BGT: Transcription profile of non-immortalized breast cancer cell lines. BMC Cancer 6: 99, 2006.
19. Muller P, Janovjak H, Miserez A and Dobbie Z: Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-1379, 2002. (Pubitemid 34619770)
20. Hamasuna R, Kataoka H, Meng J, Itoh H, Moriyama T, Wakisaka S and Koono M: Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells. Int J Cancer 93: 339-345, 2001. (Pubitemid 32592051)
21. Kasat K, Go V and Pogo BGT: Effects of pyrethroid insecticides and estrogen on WNT 10B proto-oncogene expression. Environ Int 28: 429-432, 2002. (Pubitemid 35256441)
22. Benhaj K, Akcali KC and Ozturk M: Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 15: 701-707, 2006.
23. Burdall SE, Hanby AM, Lansdown MR and Valerie S: Breast cancer cell lines: friend or foe? Breast Cancer Res 5: 89-95, 2003. (Pubitemid 36348102)
24. Bui TD, Rankin J, Smith K, Huguet EL, Ruben S, Strachan T, Harris AL and Lindsay S: A novel Wnt gene, Wnt10B, maps to 12 q and 13 and is expressed in human breast carcinomas. Oncogene 14: 1249-1253, 1997. (Pubitemid 27141929)
25. Milanovic T, Planutis K, Nguyen A, Marsh JL, Lin F, Hope C and Holcombe RF: Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. Int J Oncol 25: 1337-1342, 2004.
26. Katoh M: WNT /PCP signaling pathway and human cancer (review). Oncol Rep 14: 1583-1588, 2005.